Jefferies London Healthcare Conference 2025 November 19, 2025 11:30 AM ESTCompany ParticipantsRuxandra Draghia-Akli - Executive VP ...

For people younger than 65, U.S.-licensed flu vaccines had an estimated effectiveness of 44% to 54% that season. Among those ...

In advance of the holidays, Giant and Martin’s pharmacists are reminding customers it’s not too late to help fight the flu by ...

It has also owned a stake in Marius Pharmaceuticals, where Shah serves as Executive Chairman, and, more recently, in Novavax, where his firm's engagement helped push the struggling vaccine maker ...

BioNTech/Comirnaty Covid-19 vaccines are currently available. Read more at straitstimes.com. Read more at straitstimes.com.

Buried in a technical document released by the Centers for Medicare and Medicaid Services is a convoluted paragraph that may translate into big problems for Johnson & Johnson, Merck, and other ...

Shah Capital, Novavax's second-largest shareholder, is pressing the biotech's board to pursue strategic changes, including a ...

Shah Capital increased its stake to about 8.3% and said the gap between Novavax’s scientific potential and its commercial ...

The 2025-2026 respiratory viral season is approaching.With it comes the familiar challenge of protecting our most vulnerable ...

TAIPEI (Taiwan News) — Taiwan's Centers for Disease Control said Tuesday that 101,100 people sought emergency room treatment for flu-like illness last week, a 7.5% decrease from the previous week.

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 4 undervalued ...

Shares of Novavax have come under renewed scrutiny as analysts update their fair value estimates in light of recent strategic shifts. The consensus analyst price target for Novavax stock has edged ...